Monopar Therapeutics
(NASDAQ:MNPR)
$2.20
-0.16[-6.78%]
At close: Jul 6
$2.23
0.0300[1.36%]
PreMarket: 8:39AM EDT
Day High/Low- - -
52 Week High/Low1.7 - 6.98
Open / Close- / -
Float / Outstanding4.4M / 12.6M
Vol / Avg.- / 9.4K
Mkt Cap27.8M
P/E-
50d Avg. Price2.19
Div / Yield-
Payout Ratio-
EPS-0.19
Total Float4.4M

Monopar Therapeutics (NASDAQ:MNPR), Quotes and News Summary

Monopar Therapeutics (NASDAQ: MNPR)

Day High/Low- - -
52 Week High/Low1.7 - 6.98
Open / Close- / -
Float / Outstanding4.4M / 12.6M
Vol / Avg.- / 9.4K
Mkt Cap27.8M
P/E-
50d Avg. Price2.19
Div / Yield-
Payout Ratio-
EPS-0.19
Total Float4.4M
Sector: Health Care.Industry: Biotechnology
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.220-0.190 0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Monopar Therapeutics Questions & Answers

Q
How do I buy Monopar Therapeutics (MNPR) stock?
A

You can purchase shares of Monopar Therapeutics (NASDAQ: MNPR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Monopar Therapeutics's (MNPR) competitors?
Q
What is the target price for Monopar Therapeutics (MNPR) stock?
A

The latest price target for Monopar Therapeutics (NASDAQ: MNPR) was reported by HC Wainwright & Co. on Monday, November 1, 2021. The analyst firm set a price target for 9.00 expecting MNPR to rise to within 12 months (a possible 309.09% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Monopar Therapeutics (MNPR)?
A

The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $2.2 last updated July 6, 2022, 8:00 PM UTC.

Q
Does Monopar Therapeutics (MNPR) pay a dividend?
A

There are no upcoming dividends for Monopar Therapeutics.

Q
When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?
A

Monopar Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Monopar Therapeutics (MNPR) going to split?
A

There is no upcoming split for Monopar Therapeutics.

Q
What sector and industry does Monopar Therapeutics (MNPR) operate in?
A

Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.